nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A1—lung cancer	0.326	0.614	CbGaD
Ezogabine—CYP2A6—lung cancer	0.205	0.386	CbGaD
Ezogabine—UGT1A9—Irinotecan—lung cancer	0.0671	0.296	CbGbCtD
Ezogabine—UGT1A1—Erlotinib—lung cancer	0.0607	0.268	CbGbCtD
Ezogabine—UGT1A1—Irinotecan—lung cancer	0.0548	0.242	CbGbCtD
Ezogabine—UGT1A1—Etoposide—lung cancer	0.0439	0.194	CbGbCtD
Ezogabine—Alopecia—Etoposide—lung cancer	0.000162	0.00134	CcSEcCtD
Ezogabine—Ill-defined disorder—Cisplatin—lung cancer	0.000162	0.00134	CcSEcCtD
Ezogabine—Discomfort—Irinotecan—lung cancer	0.000161	0.00134	CcSEcCtD
Ezogabine—Hepatobiliary disease—Docetaxel—lung cancer	0.000161	0.00133	CcSEcCtD
Ezogabine—Asthenia—Topotecan—lung cancer	0.000159	0.00132	CcSEcCtD
Ezogabine—Alopecia—Paclitaxel—lung cancer	0.000159	0.00132	CcSEcCtD
Ezogabine—Osteoarthritis—Methotrexate—lung cancer	0.000159	0.00131	CcSEcCtD
Ezogabine—Confusional state—Irinotecan—lung cancer	0.000158	0.00131	CcSEcCtD
Ezogabine—Asthenia—Erlotinib—lung cancer	0.000158	0.0013	CcSEcCtD
Ezogabine—Mental disorder—Paclitaxel—lung cancer	0.000158	0.0013	CcSEcCtD
Ezogabine—Discomfort—Gemcitabine—lung cancer	0.000157	0.0013	CcSEcCtD
Ezogabine—Malaise—Cisplatin—lung cancer	0.000157	0.0013	CcSEcCtD
Ezogabine—Malnutrition—Paclitaxel—lung cancer	0.000157	0.0013	CcSEcCtD
Ezogabine—Feeling abnormal—Vinorelbine—lung cancer	0.000156	0.0013	CcSEcCtD
Ezogabine—Leukopenia—Cisplatin—lung cancer	0.000156	0.00129	CcSEcCtD
Ezogabine—Infection—Irinotecan—lung cancer	0.000156	0.00129	CcSEcCtD
Ezogabine—Shock—Irinotecan—lung cancer	0.000154	0.00128	CcSEcCtD
Ezogabine—Nervous system disorder—Irinotecan—lung cancer	0.000154	0.00127	CcSEcCtD
Ezogabine—Muscle spasms—Etoposide—lung cancer	0.000153	0.00127	CcSEcCtD
Ezogabine—Thrombocytopenia—Irinotecan—lung cancer	0.000153	0.00127	CcSEcCtD
Ezogabine—Infection—Gemcitabine—lung cancer	0.000152	0.00126	CcSEcCtD
Ezogabine—Hyperhidrosis—Irinotecan—lung cancer	0.000151	0.00125	CcSEcCtD
Ezogabine—Dizziness—Vinblastine—lung cancer	0.000151	0.00125	CcSEcCtD
Ezogabine—Urinary tract disorder—Docetaxel—lung cancer	0.00015	0.00125	CcSEcCtD
Ezogabine—Muscle spasms—Paclitaxel—lung cancer	0.00015	0.00125	CcSEcCtD
Ezogabine—Oedema peripheral—Docetaxel—lung cancer	0.00015	0.00124	CcSEcCtD
Ezogabine—Nervous system disorder—Gemcitabine—lung cancer	0.00015	0.00124	CcSEcCtD
Ezogabine—Urethral disorder—Docetaxel—lung cancer	0.000149	0.00124	CcSEcCtD
Ezogabine—Thrombocytopenia—Gemcitabine—lung cancer	0.000149	0.00124	CcSEcCtD
Ezogabine—Ill-defined disorder—Etoposide—lung cancer	0.000148	0.00123	CcSEcCtD
Ezogabine—Anxiety—Cisplatin—lung cancer	0.000148	0.00122	CcSEcCtD
Ezogabine—Vision blurred—Paclitaxel—lung cancer	0.000148	0.00122	CcSEcCtD
Ezogabine—Hyperhidrosis—Gemcitabine—lung cancer	0.000147	0.00122	CcSEcCtD
Ezogabine—Visual impairment—Docetaxel—lung cancer	0.000147	0.00122	CcSEcCtD
Ezogabine—Dizziness—Topotecan—lung cancer	0.000147	0.00122	CcSEcCtD
Ezogabine—Tremor—Paclitaxel—lung cancer	0.000147	0.00121	CcSEcCtD
Ezogabine—Liver function test abnormal—Methotrexate—lung cancer	0.000147	0.00121	CcSEcCtD
Ezogabine—Discomfort—Cisplatin—lung cancer	0.000147	0.00121	CcSEcCtD
Ezogabine—Increased appetite—Doxorubicin—lung cancer	0.000146	0.00121	CcSEcCtD
Ezogabine—Dizziness—Erlotinib—lung cancer	0.000145	0.0012	CcSEcCtD
Ezogabine—Ill-defined disorder—Paclitaxel—lung cancer	0.000145	0.0012	CcSEcCtD
Ezogabine—Malaise—Etoposide—lung cancer	0.000144	0.00119	CcSEcCtD
Ezogabine—Vertigo—Etoposide—lung cancer	0.000143	0.00119	CcSEcCtD
Ezogabine—Leukopenia—Etoposide—lung cancer	0.000143	0.00118	CcSEcCtD
Ezogabine—Eye disorder—Docetaxel—lung cancer	0.000142	0.00118	CcSEcCtD
Ezogabine—Infection—Cisplatin—lung cancer	0.000141	0.00117	CcSEcCtD
Ezogabine—Malaise—Paclitaxel—lung cancer	0.000141	0.00117	CcSEcCtD
Ezogabine—Paraesthesia—Irinotecan—lung cancer	0.000141	0.00116	CcSEcCtD
Ezogabine—Vertigo—Paclitaxel—lung cancer	0.000141	0.00116	CcSEcCtD
Ezogabine—Syncope—Paclitaxel—lung cancer	0.00014	0.00116	CcSEcCtD
Ezogabine—Loss of consciousness—Etoposide—lung cancer	0.00014	0.00116	CcSEcCtD
Ezogabine—Leukopenia—Paclitaxel—lung cancer	0.00014	0.00116	CcSEcCtD
Ezogabine—Rash—Topotecan—lung cancer	0.00014	0.00116	CcSEcCtD
Ezogabine—Dermatitis—Topotecan—lung cancer	0.00014	0.00116	CcSEcCtD
Ezogabine—Dyspnoea—Irinotecan—lung cancer	0.00014	0.00116	CcSEcCtD
Ezogabine—Nervous system disorder—Cisplatin—lung cancer	0.000139	0.00115	CcSEcCtD
Ezogabine—Somnolence—Irinotecan—lung cancer	0.000139	0.00115	CcSEcCtD
Ezogabine—Thrombocytopenia—Cisplatin—lung cancer	0.000139	0.00115	CcSEcCtD
Ezogabine—Rash—Erlotinib—lung cancer	0.000138	0.00115	CcSEcCtD
Ezogabine—Dermatitis—Erlotinib—lung cancer	0.000138	0.00115	CcSEcCtD
Ezogabine—Dyspepsia—Irinotecan—lung cancer	0.000138	0.00114	CcSEcCtD
Ezogabine—Loss of consciousness—Paclitaxel—lung cancer	0.000138	0.00114	CcSEcCtD
Ezogabine—Diplopia—Doxorubicin—lung cancer	0.000137	0.00114	CcSEcCtD
Ezogabine—Osteoarthritis—Doxorubicin—lung cancer	0.000137	0.00114	CcSEcCtD
Ezogabine—Hyperhidrosis—Cisplatin—lung cancer	0.000137	0.00114	CcSEcCtD
Ezogabine—Paraesthesia—Gemcitabine—lung cancer	0.000137	0.00113	CcSEcCtD
Ezogabine—Asthenia—Vinorelbine—lung cancer	0.000136	0.00113	CcSEcCtD
Ezogabine—Dyspnoea—Gemcitabine—lung cancer	0.000136	0.00113	CcSEcCtD
Ezogabine—Nausea—Vinblastine—lung cancer	0.000136	0.00112	CcSEcCtD
Ezogabine—Somnolence—Gemcitabine—lung cancer	0.000136	0.00112	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000135	0.00112	CcSEcCtD
Ezogabine—Fatigue—Irinotecan—lung cancer	0.000135	0.00112	CcSEcCtD
Ezogabine—Alopecia—Docetaxel—lung cancer	0.000135	0.00112	CcSEcCtD
Ezogabine—Discomfort—Etoposide—lung cancer	0.000134	0.00111	CcSEcCtD
Ezogabine—Constipation—Irinotecan—lung cancer	0.000134	0.00111	CcSEcCtD
Ezogabine—Mental disorder—Docetaxel—lung cancer	0.000134	0.00111	CcSEcCtD
Ezogabine—Anxiety—Paclitaxel—lung cancer	0.000133	0.0011	CcSEcCtD
Ezogabine—Malnutrition—Docetaxel—lung cancer	0.000133	0.0011	CcSEcCtD
Ezogabine—Nausea—Topotecan—lung cancer	0.000132	0.00109	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000132	0.00109	CcSEcCtD
Ezogabine—Discomfort—Paclitaxel—lung cancer	0.000132	0.00109	CcSEcCtD
Ezogabine—Fatigue—Gemcitabine—lung cancer	0.000132	0.00109	CcSEcCtD
Ezogabine—Confusional state—Etoposide—lung cancer	0.000131	0.00109	CcSEcCtD
Ezogabine—Constipation—Gemcitabine—lung cancer	0.00013	0.00108	CcSEcCtD
Ezogabine—Nausea—Erlotinib—lung cancer	0.00013	0.00108	CcSEcCtD
Ezogabine—Dry mouth—Paclitaxel—lung cancer	0.00013	0.00108	CcSEcCtD
Ezogabine—Infection—Etoposide—lung cancer	0.000129	0.00107	CcSEcCtD
Ezogabine—Feeling abnormal—Irinotecan—lung cancer	0.000129	0.00107	CcSEcCtD
Ezogabine—Confusional state—Paclitaxel—lung cancer	0.000129	0.00107	CcSEcCtD
Ezogabine—Dysuria—Methotrexate—lung cancer	0.000128	0.00106	CcSEcCtD
Ezogabine—Neutropenia—Methotrexate—lung cancer	0.000128	0.00106	CcSEcCtD
Ezogabine—Paraesthesia—Cisplatin—lung cancer	0.000128	0.00106	CcSEcCtD
Ezogabine—Thrombocytopenia—Etoposide—lung cancer	0.000128	0.00106	CcSEcCtD
Ezogabine—Muscle spasms—Docetaxel—lung cancer	0.000128	0.00106	CcSEcCtD
Ezogabine—Liver function test abnormal—Doxorubicin—lung cancer	0.000127	0.00105	CcSEcCtD
Ezogabine—Infection—Paclitaxel—lung cancer	0.000127	0.00105	CcSEcCtD
Ezogabine—Dyspnoea—Cisplatin—lung cancer	0.000127	0.00105	CcSEcCtD
Ezogabine—Hyperhidrosis—Etoposide—lung cancer	0.000126	0.00104	CcSEcCtD
Ezogabine—Feeling abnormal—Gemcitabine—lung cancer	0.000126	0.00104	CcSEcCtD
Ezogabine—Shock—Paclitaxel—lung cancer	0.000126	0.00104	CcSEcCtD
Ezogabine—Dizziness—Vinorelbine—lung cancer	0.000126	0.00104	CcSEcCtD
Ezogabine—Nervous system disorder—Paclitaxel—lung cancer	0.000125	0.00104	CcSEcCtD
Ezogabine—Thrombocytopenia—Paclitaxel—lung cancer	0.000125	0.00104	CcSEcCtD
Ezogabine—Hyperhidrosis—Paclitaxel—lung cancer	0.000123	0.00102	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000123	0.00102	CcSEcCtD
Ezogabine—Infestation NOS—Methotrexate—lung cancer	0.000122	0.00101	CcSEcCtD
Ezogabine—Infestation—Methotrexate—lung cancer	0.000122	0.00101	CcSEcCtD
Ezogabine—Rash—Vinorelbine—lung cancer	0.00012	0.000991	CcSEcCtD
Ezogabine—Dermatitis—Vinorelbine—lung cancer	0.00012	0.000991	CcSEcCtD
Ezogabine—Syncope—Docetaxel—lung cancer	0.000119	0.000985	CcSEcCtD
Ezogabine—Influenza—Doxorubicin—lung cancer	0.000119	0.000984	CcSEcCtD
Ezogabine—Dysphagia—Doxorubicin—lung cancer	0.000119	0.000984	CcSEcCtD
Ezogabine—Leukopenia—Docetaxel—lung cancer	0.000119	0.000983	CcSEcCtD
Ezogabine—Feeling abnormal—Cisplatin—lung cancer	0.000117	0.00097	CcSEcCtD
Ezogabine—Paraesthesia—Etoposide—lung cancer	0.000117	0.000969	CcSEcCtD
Ezogabine—Haematuria—Methotrexate—lung cancer	0.000117	0.000966	CcSEcCtD
Ezogabine—Loss of consciousness—Docetaxel—lung cancer	0.000117	0.000965	CcSEcCtD
Ezogabine—Dyspnoea—Etoposide—lung cancer	0.000116	0.000962	CcSEcCtD
Ezogabine—Somnolence—Etoposide—lung cancer	0.000116	0.000959	CcSEcCtD
Ezogabine—Hepatobiliary disease—Methotrexate—lung cancer	0.000116	0.000958	CcSEcCtD
Ezogabine—Paraesthesia—Paclitaxel—lung cancer	0.000115	0.00095	CcSEcCtD
Ezogabine—Dyspnoea—Paclitaxel—lung cancer	0.000114	0.000943	CcSEcCtD
Ezogabine—Somnolence—Paclitaxel—lung cancer	0.000114	0.00094	CcSEcCtD
Ezogabine—Nausea—Vinorelbine—lung cancer	0.000113	0.000934	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Etoposide—lung cancer	0.000112	0.000931	CcSEcCtD
Ezogabine—Dyspepsia—Paclitaxel—lung cancer	0.000112	0.000931	CcSEcCtD
Ezogabine—Asthenia—Irinotecan—lung cancer	0.000112	0.00093	CcSEcCtD
Ezogabine—Fatigue—Etoposide—lung cancer	0.000112	0.00093	CcSEcCtD
Ezogabine—Constipation—Etoposide—lung cancer	0.000111	0.000922	CcSEcCtD
Ezogabine—Neutropenia—Doxorubicin—lung cancer	0.000111	0.00092	CcSEcCtD
Ezogabine—Dysuria—Doxorubicin—lung cancer	0.000111	0.00092	CcSEcCtD
Ezogabine—Dry mouth—Docetaxel—lung cancer	0.00011	0.000915	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00011	0.000913	CcSEcCtD
Ezogabine—Fatigue—Paclitaxel—lung cancer	0.00011	0.000912	CcSEcCtD
Ezogabine—Asthenia—Gemcitabine—lung cancer	0.000109	0.000906	CcSEcCtD
Ezogabine—Constipation—Paclitaxel—lung cancer	0.000109	0.000904	CcSEcCtD
Ezogabine—Confusional state—Docetaxel—lung cancer	0.000109	0.000904	CcSEcCtD
Ezogabine—Urinary tract disorder—Methotrexate—lung cancer	0.000108	0.000898	CcSEcCtD
Ezogabine—Weight increased—Doxorubicin—lung cancer	0.000108	0.000895	CcSEcCtD
Ezogabine—Urethral disorder—Methotrexate—lung cancer	0.000108	0.000892	CcSEcCtD
Ezogabine—Infection—Docetaxel—lung cancer	0.000108	0.000891	CcSEcCtD
Ezogabine—Feeling abnormal—Etoposide—lung cancer	0.000107	0.000889	CcSEcCtD
Ezogabine—Shock—Docetaxel—lung cancer	0.000107	0.000882	CcSEcCtD
Ezogabine—Nervous system disorder—Docetaxel—lung cancer	0.000106	0.000879	CcSEcCtD
Ezogabine—Thrombocytopenia—Docetaxel—lung cancer	0.000106	0.000878	CcSEcCtD
Ezogabine—Infestation—Doxorubicin—lung cancer	0.000106	0.000877	CcSEcCtD
Ezogabine—Infestation NOS—Doxorubicin—lung cancer	0.000106	0.000877	CcSEcCtD
Ezogabine—Visual impairment—Methotrexate—lung cancer	0.000106	0.000876	CcSEcCtD
Ezogabine—Feeling abnormal—Paclitaxel—lung cancer	0.000105	0.000872	CcSEcCtD
Ezogabine—Dizziness—Irinotecan—lung cancer	0.000104	0.000858	CcSEcCtD
Ezogabine—Eye disorder—Methotrexate—lung cancer	0.000103	0.00085	CcSEcCtD
Ezogabine—Asthenia—Cisplatin—lung cancer	0.000102	0.000845	CcSEcCtD
Ezogabine—Haematuria—Doxorubicin—lung cancer	0.000101	0.000836	CcSEcCtD
Ezogabine—Hepatobiliary disease—Doxorubicin—lung cancer	0.0001	0.00083	CcSEcCtD
Ezogabine—Rash—Irinotecan—lung cancer	9.88e-05	0.000818	CcSEcCtD
Ezogabine—Dermatitis—Irinotecan—lung cancer	9.87e-05	0.000817	CcSEcCtD
Ezogabine—Paraesthesia—Docetaxel—lung cancer	9.72e-05	0.000805	CcSEcCtD
Ezogabine—Alopecia—Methotrexate—lung cancer	9.71e-05	0.000804	CcSEcCtD
Ezogabine—Dyspnoea—Docetaxel—lung cancer	9.65e-05	0.000799	CcSEcCtD
Ezogabine—Somnolence—Docetaxel—lung cancer	9.63e-05	0.000797	CcSEcCtD
Ezogabine—Mental disorder—Methotrexate—lung cancer	9.62e-05	0.000797	CcSEcCtD
Ezogabine—Rash—Gemcitabine—lung cancer	9.62e-05	0.000797	CcSEcCtD
Ezogabine—Dermatitis—Gemcitabine—lung cancer	9.61e-05	0.000796	CcSEcCtD
Ezogabine—Malnutrition—Methotrexate—lung cancer	9.56e-05	0.000792	CcSEcCtD
Ezogabine—Dyspepsia—Docetaxel—lung cancer	9.53e-05	0.000789	CcSEcCtD
Ezogabine—Urinary tract disorder—Doxorubicin—lung cancer	9.39e-05	0.000778	CcSEcCtD
Ezogabine—Oedema peripheral—Doxorubicin—lung cancer	9.37e-05	0.000776	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Docetaxel—lung cancer	9.35e-05	0.000774	CcSEcCtD
Ezogabine—Asthenia—Etoposide—lung cancer	9.35e-05	0.000774	CcSEcCtD
Ezogabine—Fatigue—Docetaxel—lung cancer	9.33e-05	0.000773	CcSEcCtD
Ezogabine—Urethral disorder—Doxorubicin—lung cancer	9.32e-05	0.000772	CcSEcCtD
Ezogabine—Nausea—Irinotecan—lung cancer	9.3e-05	0.00077	CcSEcCtD
Ezogabine—Constipation—Docetaxel—lung cancer	9.26e-05	0.000767	CcSEcCtD
Ezogabine—Visual impairment—Doxorubicin—lung cancer	9.17e-05	0.000759	CcSEcCtD
Ezogabine—Asthenia—Paclitaxel—lung cancer	9.16e-05	0.000759	CcSEcCtD
Ezogabine—Nausea—Gemcitabine—lung cancer	9.06e-05	0.00075	CcSEcCtD
Ezogabine—Vision blurred—Methotrexate—lung cancer	9.01e-05	0.000746	CcSEcCtD
Ezogabine—Rash—Cisplatin—lung cancer	8.97e-05	0.000742	CcSEcCtD
Ezogabine—Dermatitis—Cisplatin—lung cancer	8.96e-05	0.000742	CcSEcCtD
Ezogabine—Feeling abnormal—Docetaxel—lung cancer	8.92e-05	0.000739	CcSEcCtD
Ezogabine—Eye disorder—Doxorubicin—lung cancer	8.89e-05	0.000736	CcSEcCtD
Ezogabine—Ill-defined disorder—Methotrexate—lung cancer	8.87e-05	0.000735	CcSEcCtD
Ezogabine—Malaise—Methotrexate—lung cancer	8.62e-05	0.000714	CcSEcCtD
Ezogabine—Dizziness—Etoposide—lung cancer	8.62e-05	0.000713	CcSEcCtD
Ezogabine—Vertigo—Methotrexate—lung cancer	8.59e-05	0.000711	CcSEcCtD
Ezogabine—Leukopenia—Methotrexate—lung cancer	8.56e-05	0.000709	CcSEcCtD
Ezogabine—Dizziness—Paclitaxel—lung cancer	8.45e-05	0.000699	CcSEcCtD
Ezogabine—Nausea—Cisplatin—lung cancer	8.45e-05	0.000699	CcSEcCtD
Ezogabine—Alopecia—Doxorubicin—lung cancer	8.4e-05	0.000696	CcSEcCtD
Ezogabine—Mental disorder—Doxorubicin—lung cancer	8.33e-05	0.00069	CcSEcCtD
Ezogabine—Malnutrition—Doxorubicin—lung cancer	8.28e-05	0.000686	CcSEcCtD
Ezogabine—Rash—Etoposide—lung cancer	8.21e-05	0.00068	CcSEcCtD
Ezogabine—Dermatitis—Etoposide—lung cancer	8.21e-05	0.00068	CcSEcCtD
Ezogabine—Rash—Paclitaxel—lung cancer	8.05e-05	0.000667	CcSEcCtD
Ezogabine—Dermatitis—Paclitaxel—lung cancer	8.05e-05	0.000666	CcSEcCtD
Ezogabine—Discomfort—Methotrexate—lung cancer	8.04e-05	0.000666	CcSEcCtD
Ezogabine—Muscle spasms—Doxorubicin—lung cancer	7.96e-05	0.000659	CcSEcCtD
Ezogabine—Confusional state—Methotrexate—lung cancer	7.87e-05	0.000652	CcSEcCtD
Ezogabine—Vision blurred—Doxorubicin—lung cancer	7.8e-05	0.000646	CcSEcCtD
Ezogabine—Asthenia—Docetaxel—lung cancer	7.77e-05	0.000643	CcSEcCtD
Ezogabine—Infection—Methotrexate—lung cancer	7.75e-05	0.000642	CcSEcCtD
Ezogabine—Nausea—Etoposide—lung cancer	7.74e-05	0.000641	CcSEcCtD
Ezogabine—Ill-defined disorder—Doxorubicin—lung cancer	7.68e-05	0.000636	CcSEcCtD
Ezogabine—Nervous system disorder—Methotrexate—lung cancer	7.65e-05	0.000634	CcSEcCtD
Ezogabine—Thrombocytopenia—Methotrexate—lung cancer	7.64e-05	0.000633	CcSEcCtD
Ezogabine—Nausea—Paclitaxel—lung cancer	7.59e-05	0.000628	CcSEcCtD
Ezogabine—Hyperhidrosis—Methotrexate—lung cancer	7.54e-05	0.000625	CcSEcCtD
Ezogabine—Malaise—Doxorubicin—lung cancer	7.47e-05	0.000618	CcSEcCtD
Ezogabine—Vertigo—Doxorubicin—lung cancer	7.44e-05	0.000616	CcSEcCtD
Ezogabine—Syncope—Doxorubicin—lung cancer	7.42e-05	0.000615	CcSEcCtD
Ezogabine—Leukopenia—Doxorubicin—lung cancer	7.41e-05	0.000614	CcSEcCtD
Ezogabine—Loss of consciousness—Doxorubicin—lung cancer	7.28e-05	0.000603	CcSEcCtD
Ezogabine—Dizziness—Docetaxel—lung cancer	7.16e-05	0.000593	CcSEcCtD
Ezogabine—Anxiety—Doxorubicin—lung cancer	7.02e-05	0.000582	CcSEcCtD
Ezogabine—Paraesthesia—Methotrexate—lung cancer	7.01e-05	0.00058	CcSEcCtD
Ezogabine—Discomfort—Doxorubicin—lung cancer	6.96e-05	0.000577	CcSEcCtD
Ezogabine—Dyspnoea—Methotrexate—lung cancer	6.96e-05	0.000576	CcSEcCtD
Ezogabine—Somnolence—Methotrexate—lung cancer	6.94e-05	0.000574	CcSEcCtD
Ezogabine—Dry mouth—Doxorubicin—lung cancer	6.89e-05	0.000571	CcSEcCtD
Ezogabine—Dyspepsia—Methotrexate—lung cancer	6.87e-05	0.000569	CcSEcCtD
Ezogabine—Rash—Docetaxel—lung cancer	6.83e-05	0.000565	CcSEcCtD
Ezogabine—Dermatitis—Docetaxel—lung cancer	6.82e-05	0.000565	CcSEcCtD
Ezogabine—Confusional state—Doxorubicin—lung cancer	6.81e-05	0.000564	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Methotrexate—lung cancer	6.74e-05	0.000558	CcSEcCtD
Ezogabine—Fatigue—Methotrexate—lung cancer	6.73e-05	0.000557	CcSEcCtD
Ezogabine—Infection—Doxorubicin—lung cancer	6.71e-05	0.000556	CcSEcCtD
Ezogabine—Shock—Doxorubicin—lung cancer	6.65e-05	0.00055	CcSEcCtD
Ezogabine—Nervous system disorder—Doxorubicin—lung cancer	6.63e-05	0.000549	CcSEcCtD
Ezogabine—Thrombocytopenia—Doxorubicin—lung cancer	6.62e-05	0.000548	CcSEcCtD
Ezogabine—Hyperhidrosis—Doxorubicin—lung cancer	6.53e-05	0.000541	CcSEcCtD
Ezogabine—Nausea—Docetaxel—lung cancer	6.43e-05	0.000533	CcSEcCtD
Ezogabine—Feeling abnormal—Methotrexate—lung cancer	6.43e-05	0.000532	CcSEcCtD
Ezogabine—Paraesthesia—Doxorubicin—lung cancer	6.07e-05	0.000502	CcSEcCtD
Ezogabine—Dyspnoea—Doxorubicin—lung cancer	6.02e-05	0.000499	CcSEcCtD
Ezogabine—Somnolence—Doxorubicin—lung cancer	6.01e-05	0.000497	CcSEcCtD
Ezogabine—Dyspepsia—Doxorubicin—lung cancer	5.95e-05	0.000492	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Doxorubicin—lung cancer	5.83e-05	0.000483	CcSEcCtD
Ezogabine—Fatigue—Doxorubicin—lung cancer	5.83e-05	0.000482	CcSEcCtD
Ezogabine—Constipation—Doxorubicin—lung cancer	5.78e-05	0.000478	CcSEcCtD
Ezogabine—Asthenia—Methotrexate—lung cancer	5.6e-05	0.000464	CcSEcCtD
Ezogabine—Feeling abnormal—Doxorubicin—lung cancer	5.57e-05	0.000461	CcSEcCtD
Ezogabine—Dizziness—Methotrexate—lung cancer	5.16e-05	0.000427	CcSEcCtD
Ezogabine—Rash—Methotrexate—lung cancer	4.92e-05	0.000407	CcSEcCtD
Ezogabine—Dermatitis—Methotrexate—lung cancer	4.92e-05	0.000407	CcSEcCtD
Ezogabine—Asthenia—Doxorubicin—lung cancer	4.85e-05	0.000401	CcSEcCtD
Ezogabine—Nausea—Methotrexate—lung cancer	4.64e-05	0.000384	CcSEcCtD
Ezogabine—Dizziness—Doxorubicin—lung cancer	4.47e-05	0.00037	CcSEcCtD
Ezogabine—Rash—Doxorubicin—lung cancer	4.26e-05	0.000353	CcSEcCtD
Ezogabine—Dermatitis—Doxorubicin—lung cancer	4.26e-05	0.000352	CcSEcCtD
Ezogabine—Nausea—Doxorubicin—lung cancer	4.01e-05	0.000332	CcSEcCtD
Ezogabine—UGT1A1—Metabolism—MTMR3—lung cancer	2.34e-05	0.000191	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCG2—lung cancer	2.34e-05	0.000191	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTMR3—lung cancer	2.34e-05	0.000191	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTM1—lung cancer	2.34e-05	0.000191	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK3—lung cancer	2.33e-05	0.00019	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK3—lung cancer	2.33e-05	0.00019	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLBD1—lung cancer	2.32e-05	0.00019	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKR1C1—lung cancer	2.31e-05	0.000189	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ENO2—lung cancer	2.3e-05	0.000188	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HPGDS—lung cancer	2.3e-05	0.000188	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPP2R1B—lung cancer	2.28e-05	0.000186	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PGAM1—lung cancer	2.28e-05	0.000186	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PGAM1—lung cancer	2.28e-05	0.000186	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—UGT1A1—lung cancer	2.25e-05	0.000183	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTT1—lung cancer	2.23e-05	0.000182	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP1A1—lung cancer	2.22e-05	0.000181	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—EGFR—lung cancer	2.21e-05	0.000181	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—EGFR—lung cancer	2.21e-05	0.000181	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GCLC—lung cancer	2.2e-05	0.00018	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2A6—lung cancer	2.2e-05	0.00018	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ERCC2—lung cancer	2.2e-05	0.00018	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2A7—lung cancer	2.18e-05	0.000178	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2A7—lung cancer	2.18e-05	0.000178	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GNG11—lung cancer	2.17e-05	0.000177	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—lung cancer	2.16e-05	0.000176	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SDC4—lung cancer	2.13e-05	0.000174	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SDC4—lung cancer	2.13e-05	0.000174	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD17B10—lung cancer	2.12e-05	0.000173	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—KRAS—lung cancer	2.09e-05	0.000171	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—KRAS—lung cancer	2.09e-05	0.000171	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ENO1—lung cancer	2.09e-05	0.00017	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALDOA—lung cancer	2.06e-05	0.000168	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NCOA3—lung cancer	2e-05	0.000163	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CKB—lung cancer	1.98e-05	0.000161	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADCY1—lung cancer	1.95e-05	0.000159	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCG2—lung cancer	1.95e-05	0.000159	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—RRM1—lung cancer	1.94e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTA3—lung cancer	1.94e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—RRM1—lung cancer	1.94e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTA3—lung cancer	1.94e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HPGDS—lung cancer	1.91e-05	0.000156	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ENO2—lung cancer	1.91e-05	0.000156	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOA1—lung cancer	1.91e-05	0.000156	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPP2R1B—lung cancer	1.9e-05	0.000155	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2E1—lung cancer	1.87e-05	0.000153	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM2—lung cancer	1.86e-05	0.000152	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CNDP2—lung cancer	1.86e-05	0.000152	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTT1—lung cancer	1.85e-05	0.000151	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NQO1—lung cancer	1.85e-05	0.000151	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2A6—lung cancer	1.83e-05	0.000149	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GCLC—lung cancer	1.83e-05	0.000149	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—B4GALT5—lung cancer	1.83e-05	0.000149	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—B4GALT5—lung cancer	1.83e-05	0.000149	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTMR3—lung cancer	1.81e-05	0.000147	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—HRAS—lung cancer	1.78e-05	0.000145	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—HRAS—lung cancer	1.78e-05	0.000145	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTA4—lung cancer	1.78e-05	0.000145	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTA4—lung cancer	1.78e-05	0.000145	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PGAM1—lung cancer	1.76e-05	0.000144	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CG—lung cancer	1.74e-05	0.000142	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ENO1—lung cancer	1.74e-05	0.000142	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.74e-05	0.000142	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTA2—lung cancer	1.73e-05	0.000141	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTA2—lung cancer	1.73e-05	0.000141	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—lung cancer	1.7e-05	0.000139	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—lung cancer	1.7e-05	0.000139	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2A7—lung cancer	1.68e-05	0.000137	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTA1—lung cancer	1.67e-05	0.000136	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTA1—lung cancer	1.67e-05	0.000136	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—STK11—lung cancer	1.67e-05	0.000136	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—POMC—lung cancer	1.66e-05	0.000135	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCC3—lung cancer	1.65e-05	0.000135	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCC3—lung cancer	1.65e-05	0.000135	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SDC4—lung cancer	1.64e-05	0.000134	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CREBBP—lung cancer	1.61e-05	0.000132	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKR1C1—lung cancer	1.6e-05	0.00013	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKR1C1—lung cancer	1.6e-05	0.00013	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—lung cancer	1.57e-05	0.000128	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—lung cancer	1.57e-05	0.000128	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2E1—lung cancer	1.56e-05	0.000127	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—UGT1A1—lung cancer	1.55e-05	0.000127	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTP1—lung cancer	1.55e-05	0.000126	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NQO1—lung cancer	1.54e-05	0.000126	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CD—lung cancer	1.53e-05	0.000125	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—lung cancer	1.51e-05	0.000123	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAT—lung cancer	1.5e-05	0.000123	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GNG11—lung cancer	1.5e-05	0.000122	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—RRM1—lung cancer	1.5e-05	0.000122	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GNG11—lung cancer	1.5e-05	0.000122	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA3—lung cancer	1.5e-05	0.000122	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.49e-05	0.000122	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCB1—lung cancer	1.46e-05	0.000119	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TYMS—lung cancer	1.44e-05	0.000117	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDOA—lung cancer	1.43e-05	0.000116	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDOA—lung cancer	1.43e-05	0.000116	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTM1—lung cancer	1.42e-05	0.000116	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—B4GALT5—lung cancer	1.41e-05	0.000115	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—STK11—lung cancer	1.39e-05	0.000113	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NCOA3—lung cancer	1.38e-05	0.000113	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NCOA3—lung cancer	1.38e-05	0.000113	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA4—lung cancer	1.37e-05	0.000112	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.36e-05	0.000111	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADCY1—lung cancer	1.35e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCG2—lung cancer	1.35e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADCY1—lung cancer	1.35e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCG2—lung cancer	1.35e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP1A1—lung cancer	1.35e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ERCC2—lung cancer	1.34e-05	0.000109	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA2—lung cancer	1.33e-05	0.000109	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CB—lung cancer	1.33e-05	0.000109	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—lung cancer	1.32e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HPGDS—lung cancer	1.32e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO2—lung cancer	1.32e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO2—lung cancer	1.32e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HPGDS—lung cancer	1.32e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPP2R1B—lung cancer	1.31e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPP2R1B—lung cancer	1.31e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.29e-05	0.000106	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA1—lung cancer	1.29e-05	0.000105	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTP1—lung cancer	1.28e-05	0.000105	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTT1—lung cancer	1.28e-05	0.000104	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTT1—lung cancer	1.28e-05	0.000104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCC3—lung cancer	1.27e-05	0.000104	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2A6—lung cancer	1.27e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2A6—lung cancer	1.27e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GCLC—lung cancer	1.27e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GCLC—lung cancer	1.27e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.26e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAT—lung cancer	1.25e-05	0.000102	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKR1C1—lung cancer	1.23e-05	0.000101	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCB1—lung cancer	1.22e-05	9.92e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO1—lung cancer	1.2e-05	9.79e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO1—lung cancer	1.2e-05	9.79e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—UGT1A1—lung cancer	1.2e-05	9.76e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.2e-05	9.75e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TYMS—lung cancer	1.19e-05	9.74e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTM1—lung cancer	1.18e-05	9.63e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.18e-05	9.63e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOA1—lung cancer	1.15e-05	9.42e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GNG11—lung cancer	1.15e-05	9.41e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTEN—lung cancer	1.15e-05	9.4e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1A1—lung cancer	1.12e-05	9.13e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ERCC2—lung cancer	1.11e-05	9.05e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—EP300—lung cancer	1.1e-05	8.96e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDOA—lung cancer	1.1e-05	8.96e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2E1—lung cancer	1.08e-05	8.78e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2E1—lung cancer	1.08e-05	8.78e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NCOA3—lung cancer	1.07e-05	8.7e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NQO1—lung cancer	1.06e-05	8.68e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NQO1—lung cancer	1.06e-05	8.68e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CG—lung cancer	1.05e-05	8.6e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.04e-05	8.5e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADCY1—lung cancer	1.04e-05	8.47e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCG2—lung cancer	1.04e-05	8.47e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.03e-05	8.42e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HPGDS—lung cancer	1.02e-05	8.3e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO2—lung cancer	1.02e-05	8.3e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPP2R1B—lung cancer	1.01e-05	8.25e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—POMC—lung cancer	1e-05	8.19e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTT1—lung cancer	9.87e-06	8.05e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CREBBP—lung cancer	9.78e-06	7.98e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GCLC—lung cancer	9.76e-06	7.96e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOA1—lung cancer	9.6e-06	7.83e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—STK11—lung cancer	9.59e-06	7.82e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—STK11—lung cancer	9.59e-06	7.82e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CD—lung cancer	9.27e-06	7.56e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO1—lung cancer	9.25e-06	7.55e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—lung cancer	9.15e-06	7.46e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9e-06	7.35e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTP1—lung cancer	8.88e-06	7.24e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTP1—lung cancer	8.88e-06	7.24e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CG—lung cancer	8.77e-06	7.15e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAT—lung cancer	8.64e-06	7.05e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAT—lung cancer	8.64e-06	7.05e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.59e-06	7e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCB1—lung cancer	8.4e-06	6.85e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCB1—lung cancer	8.4e-06	6.85e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—POMC—lung cancer	8.34e-06	6.81e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2E1—lung cancer	8.3e-06	6.77e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TYMS—lung cancer	8.25e-06	6.73e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TYMS—lung cancer	8.25e-06	6.73e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NQO1—lung cancer	8.2e-06	6.69e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTM1—lung cancer	8.16e-06	6.65e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTM1—lung cancer	8.16e-06	6.65e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CA—lung cancer	8.13e-06	6.63e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CREBBP—lung cancer	8.13e-06	6.63e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CB—lung cancer	8.08e-06	6.59e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—lung cancer	8.01e-06	6.53e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1A1—lung cancer	7.73e-06	6.31e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1A1—lung cancer	7.73e-06	6.31e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CD—lung cancer	7.71e-06	6.29e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ERCC2—lung cancer	7.67e-06	6.26e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ERCC2—lung cancer	7.67e-06	6.26e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—lung cancer	7.61e-06	6.21e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—STK11—lung cancer	7.39e-06	6.03e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTEN—lung cancer	6.98e-06	5.7e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTP1—lung cancer	6.84e-06	5.58e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CB—lung cancer	6.72e-06	5.48e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—EP300—lung cancer	6.66e-06	5.43e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAT—lung cancer	6.66e-06	5.43e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—lung cancer	6.65e-06	5.43e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—lung cancer	6.64e-06	5.42e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOA1—lung cancer	6.63e-06	5.41e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOA1—lung cancer	6.63e-06	5.41e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCB1—lung cancer	6.48e-06	5.28e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TYMS—lung cancer	6.36e-06	5.19e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.35e-06	5.18e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM1—lung cancer	6.29e-06	5.13e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CG—lung cancer	6.06e-06	4.94e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CG—lung cancer	6.06e-06	4.94e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1A1—lung cancer	5.96e-06	4.86e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ERCC2—lung cancer	5.91e-06	4.82e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTEN—lung cancer	5.8e-06	4.73e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—POMC—lung cancer	5.76e-06	4.7e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—POMC—lung cancer	5.76e-06	4.7e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CREBBP—lung cancer	5.62e-06	4.58e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CREBBP—lung cancer	5.62e-06	4.58e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—EP300—lung cancer	5.53e-06	4.51e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CD—lung cancer	5.32e-06	4.34e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CD—lung cancer	5.32e-06	4.34e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—lung cancer	5.26e-06	4.29e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—lung cancer	5.26e-06	4.29e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOA1—lung cancer	5.11e-06	4.17e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CA—lung cancer	4.93e-06	4.02e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CG—lung cancer	4.67e-06	3.81e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CB—lung cancer	4.64e-06	3.79e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CB—lung cancer	4.64e-06	3.79e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—lung cancer	4.6e-06	3.75e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—lung cancer	4.6e-06	3.75e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—POMC—lung cancer	4.44e-06	3.63e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CREBBP—lung cancer	4.33e-06	3.53e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CD—lung cancer	4.1e-06	3.35e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CA—lung cancer	4.09e-06	3.34e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—lung cancer	4.05e-06	3.31e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—lung cancer	4.02e-06	3.28e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTEN—lung cancer	4.01e-06	3.27e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTEN—lung cancer	4.01e-06	3.27e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—EP300—lung cancer	3.82e-06	3.12e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—EP300—lung cancer	3.82e-06	3.12e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CB—lung cancer	3.58e-06	2.92e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—lung cancer	3.54e-06	2.89e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—lung cancer	3.34e-06	2.73e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTEN—lung cancer	3.09e-06	2.52e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—EP300—lung cancer	2.95e-06	2.4e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CA—lung cancer	2.83e-06	2.31e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CA—lung cancer	2.83e-06	2.31e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—lung cancer	2.31e-06	1.89e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—lung cancer	2.31e-06	1.89e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CA—lung cancer	2.18e-06	1.78e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—lung cancer	1.78e-06	1.45e-05	CbGpPWpGaD
